NURS 5335 VERIFIED MODULE 2 EXAM QUESTIONS AND
ANSWERS LATEST UPDATE
HFM Disease pharm treatment
-Treating symptoms usually resolves in 7-10 days
-Analgesics
-Topical antihistamines or anesthetics for painful lesions
HFM Disease Diphenhydramine suspension or aluminum-magnesium hydroxide
used to
Provide analgesia, anti inflammatory properties, and protective coating
HFM Disease Sucralfate used to
Provide a protective coating over oral mucosa; swish and spit or apply with Qtip
Herpangina description
Viral infection that causes fever and multiple vesicles, followed by painful mouth
ulcerations involving the soft palate, uvula, and tonsils
Herpangina etiology
-Coxsackie A most common
-Enterovirus 71
-Coxsackie B, echovirus, and adenovirus rarely
Herpangina s/s
-Abrupt onset of fever
-Severe throat pain that can cause impairment of fluid intake
-Soft palate, tonsils, uvular: 1-4mm yellow/grayish white vesicles surrounded by
erythematous halo
-Ulcers occur when vesicles rupture; 2-4mm
-Headache
-Drooling
-Coryza
-Anorexia
-Malaise
-Irritability
-GI upset
,Herpangina viral shedding
-Stool 6 weeks or longer
-Oropharynx 4 weeks or longer
Herpangina non-pharm treatment
-Maintain hydration and provide cool liquids
-Avoid spicy food
-Rest
-Return to clinic if no improvement 3-4 days
Herpangina pharm treatment
-Treatment symptomatic
-Analgesics
-Topical anesthetics
Herpangina Diphenhydramine suspension or aluminum-magnesium hydroxide
used to
Provide analgesia, anti inflammatory properties, and protective coating
Herpangina Sucralfate used to
Provide a protective coating over oral mucosa; swish and spit or apply with Qtip
Herpes Zoster description
a reactivation of the varicella-zoster virus that has lain dormant in nerve cells; involves
the skin of a single dermatone or less commonly several dermatones
Herpes Zoster risk factors
-Advancing age
-Biologic stress
-Majority of patients have no risk factors
-Immunocomp
-Emotional stress
-Treatment of a malignancy
-Spinal surgery or spinal radiation
Herpes Zoster prodrome
occurs along one or more skin dermatomes from 1-10 days
Herpes Zoster prodrome s/s
, -Itching
-Tingling
-hyperesthesia
-Burning
-Photophobia
Herpes Zoster acute phase
-Dermatonal rash erupts over 3-4 days: expect unilateral
-Fever, malaise, headache
-Maculopapular rash that progresses to grouped vesicles on an erythematous base, and
then pustules in 3-4 days. Successive crops of vesicles may appear for up to a week
-Pain possibly severe
Herpes Zoster convalescent phase
-Within 2-3 weeks, rash resolves
-Pain
Herpes Zoster postherpatic neuralgia
-Common in older adults and may last months
-Constant burning or aching pain and its intermittent shock like pain in response to
normally non painful stimulus
Herpes Zoster vaccine
-Shingrix preferred by CDC
-Give to healthy adults >50
-2 doses separated by 2-6 months
Herpes Zoster non pharm treatment
-Domeboro soaked wet compresses several times a day to dermatonal rash
-Avoid contact with known patients if member of high risk group
-Cant transmit shingles but can transmit varicella
Herpes Zoster pharm treatment
-Antiviral may shorten length and severity
-Analgesics
-Antipuritics such as calamine or colloid oatmeal baths
-Topical lidocaine or nerve blocking agents
ANSWERS LATEST UPDATE
HFM Disease pharm treatment
-Treating symptoms usually resolves in 7-10 days
-Analgesics
-Topical antihistamines or anesthetics for painful lesions
HFM Disease Diphenhydramine suspension or aluminum-magnesium hydroxide
used to
Provide analgesia, anti inflammatory properties, and protective coating
HFM Disease Sucralfate used to
Provide a protective coating over oral mucosa; swish and spit or apply with Qtip
Herpangina description
Viral infection that causes fever and multiple vesicles, followed by painful mouth
ulcerations involving the soft palate, uvula, and tonsils
Herpangina etiology
-Coxsackie A most common
-Enterovirus 71
-Coxsackie B, echovirus, and adenovirus rarely
Herpangina s/s
-Abrupt onset of fever
-Severe throat pain that can cause impairment of fluid intake
-Soft palate, tonsils, uvular: 1-4mm yellow/grayish white vesicles surrounded by
erythematous halo
-Ulcers occur when vesicles rupture; 2-4mm
-Headache
-Drooling
-Coryza
-Anorexia
-Malaise
-Irritability
-GI upset
,Herpangina viral shedding
-Stool 6 weeks or longer
-Oropharynx 4 weeks or longer
Herpangina non-pharm treatment
-Maintain hydration and provide cool liquids
-Avoid spicy food
-Rest
-Return to clinic if no improvement 3-4 days
Herpangina pharm treatment
-Treatment symptomatic
-Analgesics
-Topical anesthetics
Herpangina Diphenhydramine suspension or aluminum-magnesium hydroxide
used to
Provide analgesia, anti inflammatory properties, and protective coating
Herpangina Sucralfate used to
Provide a protective coating over oral mucosa; swish and spit or apply with Qtip
Herpes Zoster description
a reactivation of the varicella-zoster virus that has lain dormant in nerve cells; involves
the skin of a single dermatone or less commonly several dermatones
Herpes Zoster risk factors
-Advancing age
-Biologic stress
-Majority of patients have no risk factors
-Immunocomp
-Emotional stress
-Treatment of a malignancy
-Spinal surgery or spinal radiation
Herpes Zoster prodrome
occurs along one or more skin dermatomes from 1-10 days
Herpes Zoster prodrome s/s
, -Itching
-Tingling
-hyperesthesia
-Burning
-Photophobia
Herpes Zoster acute phase
-Dermatonal rash erupts over 3-4 days: expect unilateral
-Fever, malaise, headache
-Maculopapular rash that progresses to grouped vesicles on an erythematous base, and
then pustules in 3-4 days. Successive crops of vesicles may appear for up to a week
-Pain possibly severe
Herpes Zoster convalescent phase
-Within 2-3 weeks, rash resolves
-Pain
Herpes Zoster postherpatic neuralgia
-Common in older adults and may last months
-Constant burning or aching pain and its intermittent shock like pain in response to
normally non painful stimulus
Herpes Zoster vaccine
-Shingrix preferred by CDC
-Give to healthy adults >50
-2 doses separated by 2-6 months
Herpes Zoster non pharm treatment
-Domeboro soaked wet compresses several times a day to dermatonal rash
-Avoid contact with known patients if member of high risk group
-Cant transmit shingles but can transmit varicella
Herpes Zoster pharm treatment
-Antiviral may shorten length and severity
-Analgesics
-Antipuritics such as calamine or colloid oatmeal baths
-Topical lidocaine or nerve blocking agents
